Prolonged vs Intermittent Infusions of beta-Lactam Antibiotics in Adults With Sepsis or Septic Shock: A Systematic Review and Meta-Analysis.
Abdul-Aziz MH, Hammond NE, Brett SJ, Cotta MO, De Waele JJ, Devaux A, Di Tanna GL, Dulhunty JM, Elkady H, Eriksson L, Hasan MS, Khan AB, Lipman J, Liu X, Monti G, Myburgh J, Novy E, Omar S, Rajbhandari D, Roger C, Sjövall F, Zaghi I, Zangrillo A, Delaney A, Roberts JA.
JAMA. 2024 Aug 27;332(8):638-648. doi: 10.1001/jama.2024.9803.
PMID:38864162
Mechanisms of hepatotoxicity associated with the monocyclic beta-lactam antibiotic BAL30072.
Paech F, Messner S, Spickermann J, Wind M, Schmitt-Hoffmann AH, Witschi AT, Howell BA, Church RJ, Woodhead J, Engelhardt M, Krähenbühl S, Maurer M.
Arch Toxicol. 2017 Nov;91(11):3647-3662. doi: 10.1007/s00204-017-1994-x. Epub 2017 May 23.
PMID:28536862
An investigation of broad-spectrum antibiotic-induced liver injury based on the FDA Adverse Event Reporting System and retrospective observational study.
Shiraishi C, Kato H, Ogura T, Iwamoto T.
Sci Rep. 2024 Aug 6;14(1):18221. doi: 10.1038/s41598-024-69279-6.
PMID:39107511
Identification of flucloxacillin-modified hepatocellular proteins: implications in flucloxacillin-induced liver injury.
Ali SE, Waddington JC, Lister A, Sison-Young R, Jones RP, Rehman AH, Goldring CEP, Naisbitt DJ, Meng X.
Toxicol Sci. 2023 Mar 20;192(1):106-116. doi: 10.1093/toxsci/kfad015.
PMID:36782357
Antimicrobial peptides as a promising treatment option against Acinetobacter baumannii infections.
Neshani A, Sedighian H, Mirhosseini SA, Ghazvini K, Zare H, Jahangiri A.
Microb Pathog. 2020 Sep;146:104238. doi: 10.1016/j.micpath.2020.104238. Epub 2020 May 5.